Inventor · disambiguated record
Ronald G. Schultz
Also filed as: SCHULTZ RONALD G
16 granted patents·2,294 citations·filing 1994–2017
96Inventor score
Top patents by PatentIndex Score
16 records- 0198US7321029B22′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2001·Granted Jan 22, 2008·219 cites·20 claims
- 0298US6169170B1Oligonucleotide N3′→N5′Phosphoramidate DuplexesLYNX THERAPEUTICS INC·Filed 1997·Granted Jan 2, 2001·436 cites·13 claims
- 0397US5965720AOligonucleotide N3'→P5' phosphoramidatesLYNX THERAPEUTICS INC·Filed 1995·Granted Oct 12, 1999·267 cites·12 claims
- 0496US5591607AOligonucleotide N3→P5' phosphoramidates: triplex DNA formationLYNX THERAPEUTICS INC·Filed 1995·Granted Jan 7, 1997·264 cites·16 claims
- 0595US5837835AOligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance propertiesLYNX THERAPEUTICS INC·Filed 1995·Granted Nov 17, 1998·155 cites·7 claims
- 0695US5726297AOligodeoxyribonucleotide N3' P5' phosphoramidatesLYNX THERAPEUTICS INC·Filed 1995·Granted Mar 10, 1998·262 cites·29 claims
- 0794US5684143AOligo-2'-fluoronucleotide N3'->P5' phosphoramidatesLYNX THERAPEUTICS INC·Filed 1996·Granted Nov 4, 1997·177 cites·16 claims
- 0894US5631135AOligonucleotide N3'→P5' phosphoramidates: hybridization and nuclease resistance propertiesLYNX THERAPEUTICS INC·Filed 1995·Granted May 20, 1997·164 cites·40 claims
- 0994US5599922AOligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance propertiesLYNX THERAPEUTICS INC·Filed 1994·Granted Feb 4, 1997·245 cites·32 claims
- 1091US7989603B22′-arabino-fluorooligonucleotide N3′-P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2007·Granted Aug 2, 2011·8 cites·5 claims
- 1188US8377644B22′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2011·Granted Feb 19, 2013·8 cites·9 claims
- 1287US8906615B22′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2013·Granted Dec 9, 2014·3 cites·10 claims
- 1378US5824793ASolid phase synthesis of oligonucleotide N3'-P5' phosphoramidatesLYNX THERAPEUTICS INC·Filed 1996·Granted Oct 20, 1998·48 cites·58 claims
- 1474US5859233ASynthons for synthesis of oligonucleotide N3-P5 phosphoramidatesLYNX THERAPEUTICS INC·Filed 1996·Granted Jan 12, 1999·38 cites·8 claims
- 1568US10358459B22′-arabino-fluorooligonucleotide N3′˜P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2017·Granted Jul 23, 2019·0 cites·12 claims
- 1668US9765109B22′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2014·Granted Sep 19, 2017·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Ronald G. Schultz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →